Total Payments
$20,307
2024 Payments
$2,753
Companies
71
Transactions
1,404
Medicare Patients
9,006
Medicare Billing
$522,336
Payment Breakdown by Category
Food & Beverage$20,198 (99.5%)
Education$109.12 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,198 | 1,395 | 99.5% |
| Education | $109.12 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,002 | 148 | $0 (2024) |
| Novo Nordisk Inc | $1,484 | 96 | $0 (2024) |
| PFIZER INC. | $1,292 | 99 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,229 | 113 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,146 | 76 | $0 (2024) |
| Amgen Inc. | $1,126 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,028 | 83 | $0 (2024) |
| Lilly USA, LLC | $988.23 | 70 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $926.11 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $916.48 | 71 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,753 | 160 | ABBVIE INC. ($397.64) |
| 2023 | $3,053 | 198 | ABBVIE INC. ($404.89) |
| 2022 | $2,844 | 195 | ABBVIE INC. ($552.88) |
| 2021 | $2,283 | 156 | AbbVie Inc. ($366.27) |
| 2020 | $1,228 | 81 | Janssen Pharmaceuticals, Inc ($133.06) |
| 2019 | $2,758 | 202 | Novartis Pharmaceuticals Corporation ($297.31) |
| 2018 | $2,679 | 204 | Novo Nordisk Inc ($286.33) |
| 2017 | $2,710 | 208 | Boehringer Ingelheim Pharmaceuticals, Inc. ($271.48) |
All Payment Transactions
1,404 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: VACCINES | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: VACCINE | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.78 | General |
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: PAIN | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PAIN | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Insomnia | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,161 | 2,792 | $479,465 | $107,633 |
| 2022 | 19 | 2,290 | 3,068 | $514,334 | $119,471 |
| 2021 | 20 | 2,399 | 3,056 | $500,808 | $118,264 |
| 2020 | 19 | 2,156 | 2,716 | $471,434 | $176,969 |
Total Patients
9,006
Total Services
11,632
Medicare Billing
$522,336
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 326 | 514 | $72,988 | $19,369 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 442 | 442 | $99,450 | $17,628 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 504 | 788 | $164,692 | $14,374 | 8.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 187 | $30,107 | $11,028 | 36.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 143 | 143 | $11,726 | $10,841 | 92.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $17,457 | $9,292 | 53.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 47 | $21,103 | $5,817 | 27.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 143 | 146 | $5,986 | $4,187 | 70.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 45 | $10,395 | $4,037 | 38.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 26 | 26 | $8,294 | $3,191 | 38.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 306 | 306 | $15,912 | $2,288 | 14.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 28 | 30 | $4,830 | $1,816 | 37.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 20 | $4,740 | $1,632 | 34.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 30 | 30 | $10,350 | $1,128 | 10.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $1,435 | $1,004 | 70.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 320 | 523 | $74,266 | $20,996 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 430 | 430 | $96,750 | $17,483 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 520 | 805 | $168,245 | $15,869 | 9.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 246 | $39,606 | $13,441 | 33.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 144 | 145 | $11,570 | $9,928 | 85.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 56 | $25,144 | $7,953 | 31.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 25 | 25 | $13,225 | $6,951 | 52.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 64 | $14,784 | $5,029 | 34.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 146 | 147 | $6,027 | $3,991 | 66.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 30 | 30 | $9,570 | $3,828 | 40.0% |
About Dr. Mark Galles, M.D
Dr. Mark Galles, M.D is a Internal Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982681482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Galles, M.D has received a total of $20,307 in payments from pharmaceutical and medical device companies, with $2,753 received in 2024. These payments were reported across 1,404 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($20,198).
As a Medicare-enrolled provider, Galles has provided services to 9,006 Medicare beneficiaries, totaling 11,632 services with total Medicare billing of $522,336. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tulsa, OK
- Active Since 12/27/2005
- Last Updated 09/16/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982681482
Products in Payments
- ENTRESTO (Drug) $893.23
- XARELTO (Drug) $825.54
- UBRELVY (Drug) $768.82
- JARDIANCE (Drug) $727.16
- TRELEGY ELLIPTA (Drug) $645.75
- ELIQUIS (Drug) $638.89
- JANUVIA (Drug) $563.13
- FARXIGA (Drug) $525.44
- XIFAXAN (Drug) $462.23
- Vascepa (Drug) $398.55
- EVENITY (Biological) $383.92
- Kerendia (Drug) $327.41
- TRULICITY (Drug) $326.90
- MOUNJARO (Drug) $324.15
- VRAYLAR (Drug) $302.10
- Livalo (Drug) $301.02
- REXULTI (Drug) $291.02
- LINZESS (Drug) $289.89
- CHANTIX (Drug) $269.80
- BELSOMRA (Drug) $263.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tulsa
Dr. Anuj Malik, Md, MD
Internal Medicine — Payments: $559,128
Internal Medicine $559,128
Mousumi Som, Do, DO
Internal Medicine — Payments: $182,416
Internal Medicine $182,416
Madhuri Lad, D.o, D.O
Internal Medicine — Payments: $160,090
Internal Medicine $160,090
Jesse Richards, D.o, D.O
Internal Medicine — Payments: $147,415
Internal Medicine $147,415
Dr. Stacy Chronister, D.o, D.O
Internal Medicine — Payments: $118,921
Internal Medicine $118,921
Mr. Eugene Ichinose, M.d, M.D
Internal Medicine — Payments: $113,876
Internal Medicine $113,876